Optos PLC, a pioneer and leader in retinal imaging technology, announces the launch of MonacoPro, the next generation ultra-widefield (UWF) SLO and spectral domain retinal imaging solution.
Building on the legacy of Monaco, MonacoPro introduces features designed to elevate diagnostic precision, and streamline workflow for eyecare professionals worldwide.
“MonacoPro represents our commitment to continuous innovation in ophthalmic imaging,” said Optos CEO Robert Kennedy. “With new advancements in automation, and data analysis, we are empowering clinicians with tools that enhance efficiency and diagnostic confidence while maintaining our industry-leading ultra-widefield imaging capabilities.”
Key product features:
• MonacoPro OCT Image Quality for Demanding Practices
New MonacoPro OCT image quality provides highly detailed and precise retinal images that meet the needs of even the most demanding eyecare practices. With MonacoPro, practitioners can visualize and analyze retinal layers with greater accuracy, supporting diagnosis and treatment planning. When combined with the integrated 200° single-shot optomap imaging, MonacoPro increases the identification of macular pathology when compared with fundus imaging alone by 29.4%.1
• AreaAssist: Streamlined Efficiency for Enhanced Workflow
MonacoPro also marks the introduction of the new AreaAssist tool, designed to improve the efficiency of retinal imaging workflows. AreaAssist enables users to automatically measure continuous areas of matching color and adjust the sensitivity of the selected area with a simple “click and drag” of the mouse. By automating and simplifying these processes, AreaAssist removes the need for time-consuming manual tasks, allowing practitioners to focus on patient care and clinical decision-making.
• One of the Largest Reference Databases in Retinal Imaging
The Optos Reference Database in the US market, on the MonacoPro now includes 879 eyes and stratifies based on different optic disc sizes in addition to age. Research has demonstrated that normalizing reference data by ONH size is a more effective approach than other criteria for identifying relevant population data, leading to greater diagnostic precision.2
Optos remains dedicated to advancing retinal imaging technology to support eyecare professionals in diagnosing and managing ocular pathology with greater confidence.
The launch of MonacoPro underscores the ongoing investment in cutting-edge solutions that drive efficiency, enhance clinical accuracy, and improve patient outcomes.
MonacoPro will be available for shipping beginning in March 2025.
For more information about MonacoPro and industry-leading retinal imaging technology by Optos, please visit www.optos.com.